Life sciences news
-
Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study
Thursday July 15th 2021
Read more
-
Galapagos demonstrates early clinical activity with SIK2/3 inhibition in inflammation
Thursday July 15th 2021
Read more
-
Sequana Medical announces positive results from second interim analysis of North American pivotal alfapump® study (POSEIDON)
Thursday July 1st 2021
Read more
-
Mithra completes recruitment of Covid-19 Phase II Study
Thursday June 17th 2021
Read more
-
Precigen ActoBio announces positive topline results from Phase 1b/2a Study of AG019 ActoBiotics™
Monday June 14th 2021
Read more
-
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
Friday June 4th 2021
Read more
-
Galapagos announces first patient enrolled in FILOSOPHY study to advance understanding of Jyseleca (filgotinib) effectiveness and safety in a real-world setting
Wednesday May 19th 2021
Read more
-
Sequana Medical announces strong top-line results from RED DESERT alfapump DSR® study and expansion of DSR® development programme
Tuesday May 11th 2021
Read more
-
Your news here?
-
New cancer immunotherapy treatment enters clinical phase
Thursday April 29th 2021
Read more
-
Precirix partners with Evergreen to expand North American clinical trial supply
Wednesday April 28th 2021
Read more
-
ViroVet successful with second vaccine based on new vaccine technology, Rega Institute assesses development of human version
Monday March 22nd 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator